Breaks Categories: News

MondayDec 12, 2016 1:36 pm

NetworkNewsBreaks – Jaguar Animal Health (JAGX) Inks Distribution Deal with Henry Shein, Inc.; Shares Spike

Shares of Jaguar Animal Health, Inc. (NASDAQ: JAGX) are up 23%, triggered by news of the company’s agreement with Henry Schein, Inc. for one year of exclusive distribution of Jaguar’s Neonorm™ Foal product to the U.S. equine market. “We are very excited to have the support of one the world’s leading companion animal health distribution companies in our effort to drive sales of Neonorm™ Foal throughout the U.S. equine market,” Lisa Conte, Jaguar’s president and CEO, stated in the news release. “We look forward to leveraging the great exposure that Neonorm™ Foal received at last week’s AAEP conference and collaborating closely…

Continue Reading

MondayDec 12, 2016 1:33 pm

NetworkNewsBreaks – Neuralstem, Inc. (CUR) Shares Higher; finalizes $20M Strategic Investment from Tianjin Pharmaceutical Group

Neuralstem (NASDAQ: CUR) is trading 9% higher after reporting the close of a $20 million investment from Tianjin Pharmaceutical Group International Holdings Co., LTD in an arrangement Neuralstem says will “complement and support” R&D initiatives. Tianjin received 28.5 million shares of common stock and 1 million shares of Series A convertible preferred stock that cannot be converted if the shares received and the common shares would result in Tianjin having voting power in excess of 19.99% of the company. Tianjin is also authorized to appoint one member to the company’s board of directors. To view the full press release, visit:…

Continue Reading

FridayDec 09, 2016 2:13 pm

NetworkNewsBreaks – A. M. Castle & Co. (CASL) Secures $112M in new Secured Term Credit Facilities

A. M. Castle & Co. (OTCQB: CASL) closed a definitive agreement for new credit facilities of $112 million, which the company intends to use to repay outstanding borrowings and support the continuance of letters of credit, totaling $53.2 million under a former revolving loan and security agreement. “These new credit facilities will enhance Castle’s liquidity and better position the Company to advance its ongoing efforts to capitalize on market opportunities. We are excited to have the support of the financial institutions funding the Credit Facilities,” Castle president and CEO Steve Scheinkman stated in the news release. To view the full…

Continue Reading

FridayDec 09, 2016 2:00 pm

NetworkNewsBreaks – Long Island Iced Tea Corp. (LTEA) Inks First Acquisition Deal; Shares Tick Higher

Long Island Iced Tea Corp. (NASDAQ: LTEA) this morning said it will acquire the ALO Juice® beverage brand and trademark rights from The Wilnah International, LLC for a purchase price of 5,000 shares of the company's common stock. The company has been distributing ALO Juice® since February 2016, with nearly $1 million worth sold to date. The closing of the transaction is anticipated for the first quarter of 2017, subject to customary conditions. "ALO Juice® is a quality brand. We are excited that it will mark the first brand acquisition in our five-year history," Long Island Iced Tea CEO Philip…

Continue Reading

ThursdayDec 08, 2016 1:59 pm

NetworkNewsBreaks – Anavex Life Sciences (AVXL) Releases Positive Data for ANAVEX 2-73 in Alzheimer’s Study; Trading Higher

Shares of Anavex Life Sciences (NASDAQ: AVXL) are higher after the company said its ANAVEX 2-73 candidate met primary and secondary endpoints in a phase 2a study of patients with mild-to-moderate Alzheimer’s disease (AD). ANAVEX 2-73 was well tolerated and there were no clinically significant treatment-related adverse events and no serious adverse events. Despite non-optimized dosing of ANAVEX 2-73 throughout the 12-month study, continued significant improvements from baseline of cognitive, functional and behavioral scores in a group of patients were observed, respectively. "We believe this data gives us a solid foundation from which to continue the next phase of rationally…

Continue Reading

WednesdayDec 07, 2016 1:02 pm

NetworkNewsBreaks – Broadwind Energy (BWEN) Receives New Tower Orders Valued at $23M

Broadwind Energy (NASDAQ: BWEN) this morning said it recently received $23 million in new tower orders for 2017 delivery. The company will produce these towers in its Manitowoc, Wisconsin, and Abilene, Texas, facilities. “We have booked over $250 million in new tower orders so far in 2016.  Both of our tower manufacturing facilities are operating consistently and a good portion of our 2017 capacity is under contract. We are proud of the contributions our highly-skilled team is making to U.S. manufacturing and to the wind industry,” Stephanie Kushner, president and CEO of Broadwind, stated in the news release. To view…

Continue Reading

WednesdayDec 07, 2016 1:00 pm

NetworkNewsBreaks – Bridgeline Digital (BLIN) Trading Higher on $1.5M Deal with Global Engines Manufacturer

Bridgeline Digital (NASDAQ: BLIN) released news this morning that its iAPPS platform has been selected to power one of the world’s largest engine manufacturers’ eCommerce website in a deal expected to total more than $1.5 million in iAPPS licenses, hosting and associated professional services. In making its selection, the engine manufacturer noted iAPPS’s ability for simple globalization, multi-site management and intuitive digital marketing capabilities. “This company needed a system that took care of all of the basics when it came to their online commerce presence, while layering on the necessary personalization and digital marketing functionality to drive engagement and conversions.…

Continue Reading

MondayDec 05, 2016 4:00 pm

NetworkNewsBreaks – EyeGate (EYEG) Announces Positive Data from Third Stage of Phase Ib/IIa Clinical Trial of EGP-437

EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today reported promising data from the third stage of its phase Ib/IIa trial assessing iontophoretic EGP-437 for the treatment of ocular inflammation and pain in post-surgical cataract patients. Consistent with the first two stages of the trial, the procedure was very well tolerated in all subjects. Stage three of this multi-center, open-label clinical trial enrolled 30 subjects who have undergone cataract surgery with implantation of a posterior chamber intraocular lens (“IOL”). Patients were divided into three groups receiving iontophoretic doses of EGP-437 at either 4.5 mA-min or 14.0 mA-min, or a placebo at 14.0 mA-min.…

Continue Reading

MondayDec 05, 2016 3:58 pm

NetworkNewsBreaks – Ocean Power Technologies (OPTT) Signs Joint Marketing Agreement with Sonalysts

In a news release issued earlier today, Ocean Power Technologies, Inc. (NASDAQ: OPTT) and Sonalysts, Inc. announced their entry into a joint marketing agreement in defense and oil and gas applications where persistent power, real-time data collection, processing, and transmission are critical. OPTT’s PB3 PowerBuoy® is a power and communication platform for remote offshore applications that enables the use of advanced multi-functional sensors and autonomous underwater vehicles. Sonalysts maintains core technology in undersea wireless communications and in autonomous undersea systems analysis, which are available to a variety of commercial and defense customers such as the U.S. Navy Submarine Force. “We…

Continue Reading

MondayDec 05, 2016 3:54 pm

NetworkNewsBreaks – Cerecor (CERC) Phase 2 Study Top-Line Results of CERC-501 Display Favorable Side-Effect Profile

Cerecor Inc. (NASDAQ: CERC) announced top-line clinical results from its nicotine withdrawal phase 2 clinical trial of CERC-501 today. Although the trial did not meet its primary objective in nicotine withdrawal, the oral, potent, and selective kappa opioid receptor ("KOR") antagonist was well tolerated with no serious adverse events reported and no discontinuations due to adverse events. Based on this favorable side-effect profile, the company intends to move forward with its previously planned development of CERC-501 in its primary indication, as an adjunctive treatment of Major Depressive Disorder (MDD). "There is preclinical and recent clinical evidence that strongly support the potential…

Continue Reading